アレルギー性鼻炎とは
Alexander N Greiner1, Peter W Hellings, Guiseppina Rotiroti
1Asthma and Allergy Centre, San Diego, CA, USA.
Lancet (London, England)
|July 26, 2011
まとめ
アレルギー性鼻炎は,しばしば見過ごされ,健康と生産性に影響を与えます. 効果的な管理には,ガイドラインに基づくケア,薬物療法,アレルゲン特異性免疫療法などがあり,生活の質を向上させる.
科学分野:
- アレルギー学と免疫学
- 肺内科 肺内科 肺内科
- クリニカル・メディシン 臨床医学
背景:
- アレルギー性鼻炎は,すべての年齢層に影響を及ぼす一般的な状態であり,しばしば診断不足と虐待につながります.
- 生命を脅かすものではないにもかかわらず,生活の質,生産性に大きな影響を与え,貧弱な喘息コントロールと関連しています.
- 現在の経営陣はしばしば失敗しており,ガイドラインに基づくアプローチの必要性を強調しています.
研究 の 目的:
- アレルギー性鼻炎の臨床的関連性と社会的コストを強調する.
- 現在の管理戦略を見直し,正確な診断の重要性を強調する.
- アレルギー性鼻炎に対する様々な治療法の有効性と安全性について議論する.
主な方法:
- アレルギー性鼻炎の診断と管理に関する既存の文献のレビュー.
- 鼻内コルチコステロイドおよび免疫療法を含む薬剤療法オプションの分析.
- 特定のIgE反応性検査による診断確認を重視する.
主要な成果:
- 鼻内用コルチコステロイドは,アレルギー性鼻炎の症状の治療において,有効性と安全性において優越性を示しています.
- 特定のIgE反応性テストは,診断と環境制御戦略の指針を決定的に重要です.
- 免疫療法は,アレルギー性鼻炎の自然な経過を修正する可能性を秘めています.
結論:
- 効果的なアレルギー性鼻炎の管理には,ガイドラインの遵守,正確な診断,そして人為的な治療が必要です.
- 薬剤療法,特に鼻内用コルチコステロイドは有効ですが,免疫療法は病気の修正の可能性を持っています.
- 患者の教育とさらなる研究は,持続的な症例の治療結果を改善するために不可欠です.
関連する概念動画
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions
Overview
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

